Skip to main content
PATRYS LIMITED logo

PATRYS LIMITED — Investor Relations & Filings

Ticker · PAB ISIN · AU000000PAB9 ASX Professional, scientific and technical activities
Open in API
Filings indexed 916 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country AU Australia
Listing ASX PAB

About PATRYS LIMITED

https://patrys.com/

Patrys Limited is a biotechnology company focused on the development of novel antibody-based therapies for the treatment of cancer. The company's primary platform is based on Deoxymabs, a suite of antibodies derived from the 3E10 lupus autoantibody. These antibodies possess the unique capability to cross cell membranes and the blood-brain barrier, targeting the cell nucleus to inhibit DNA damage repair mechanisms. Patrys' lead candidates, PAT-DX1 and PAT-DX3, are engineered to exploit the DNA repair deficiencies inherent in many cancer cells, particularly aggressive forms such as glioblastoma and triple-negative breast cancer. Beyond direct anti-tumor activity, the Deoxymab platform is designed for use in synthetic lethality applications and as a delivery vehicle for therapeutic payloads, including nanoparticles and imaging agents, to target primary and metastatic tumors.

Recent filings

Filing Released Lang Actions
Patrys advances RLS-2202 toward Phase 1 Clinical Trial 3 pages 372.7KB
Regulatory Filings Classification · 82% confidence The document is a corporate press release announcing the appointment of a clinical trial site (CMAX) and a CRO (Alithia) for Patrys Limited’s Phase 1A clinical trial. It contains no financial statements, regulatory certifications, board or management changes, voting results, dividends, M&A activity, or other specialized content. It is not the issuance of a report or spreadsheet but rather an operational update to shareholders via a regulatory announcement. This aligns with the fallback “Regulatory Filings” category for general announcements that do not fit other specific classes.
2026-05-19 English
Appendix 4C - Quarterly - 31 March 2026 - Updated 11 pages 1.0MB
Interim / Quarterly Report Classification · 98% confidence The document is an ASX Quarterly Activities Report coupled with an Appendix 4C cash flow statement for the period ended 31 March 2026. It contains substantive financial data (detailed cash flow tables, operating metrics) and narrative operations updates for the quarter. This is not merely an announcement of publication but the actual quarterly report itself. Therefore, it should be classified as an Interim / Quarterly Report. Q3 2026
2026-05-14 English
Notice of General Meeting/Proxy Form 30 pages 618.6KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING AND EXPLANATORY MEMORANDUM' and details the agenda for a General Meeting of shareholders, including resolutions to approve share placements, options issuance, and related voting exclusion statements. It is a notice and explanatory memorandum for a shareholder meeting, not a financial report or earnings release. The content focuses on shareholder voting matters and capital raising approvals, typical of a proxy solicitation or meeting notice document. It is not a full annual or interim report, nor an earnings release or audit report. The document is lengthy (15,000 characters) and contains detailed resolutions and voting instructions, consistent with materials sent to shareholders to inform and solicit votes for a meeting. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI).
2026-05-05 English
Letter to Shareholders - General Meeting 1
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a notice to shareholders about an upcoming General Meeting (GM) of Patrys Limited, including details on the meeting date, location, and voting instructions. It references the Notice of Meeting and Explanatory Memorandum but does not contain the actual Notice or any voting results. The document is short (2414 characters) and serves as an announcement or invitation to the meeting rather than the meeting materials themselves or the voting results. Therefore, it fits best as a Proxy Solicitation & Information Statement (PSI) or a related meeting notice. However, since it primarily informs shareholders about the meeting and how to access the Notice rather than soliciting votes directly or providing detailed meeting materials, it aligns most closely with Proxy Solicitation & Information Statement (PSI).
2026-05-05 English
Appendix 4C - Quarterly - 31 March 2026 10 pages 775.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C' for the period ended 31 March 2026. It contains detailed operational updates, clinical and regulatory progress, leadership and governance changes, funding and balance sheet information, and a comprehensive cash flow statement (Appendix 4C) with financial data for the quarter. The presence of substantive financial data and analysis for a quarter shorter than a full fiscal year, along with operational and strategic updates, aligns with the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement or a brief summary but a full quarterly report with financial statements and business commentary. Therefore, it should be classified as an Interim / Quarterly Report (IR). Q3 2026
2026-04-29 English
Application for quotation of securities - PAB 6 pages 18.5KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form titled 'Application for quotation of securities' submitted by Patrys Limited. It details the application for listing new securities on the ASX, including the number of securities, issue price, and references to previous announcements (Appendix 3B). This type of document is a formal application to the stock exchange for quotation of securities and is not a financial report, earnings release, or management information. It is a regulatory announcement related to capital markets compliance and listing requirements. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-04-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.